Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
MEDETOMIDINE HYDROCHLORIDE
Laboratorios Syva, S.A.U
QN05CM91
MEDETOMIDINE HYDROCHLORIDE
1 Mg/Ml
Solution for Injection
VPO-Vet.Practitioner Only
Canine, Feline
Medetomidine
Neurological Preparations
Authorised
2012-03-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dorbene vet 1 mg/ml solution for injection for dogs and cats. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution for injection contains: ACTIVE SUBSTANCE: Medetomidine hydrochloride 1.0 mg (equivalent to 0.85 mg medetomidine) EXCIPIENTS: Methyl parahydroxybenzoate (E 218) 1.0 mg Propyl parahydroxybenzoate (E 216) 0.2 mg For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. Clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _In dogs and cats:_ Sedation to facilitate handling. Premedication prior to general anaesthesia. _In cats:_ In combination with ketamine for general anaesthesia for minor surgical procedures of short duration. 4.3 CONTRAINDICATIONS Do not use in animals with: - Severe cardiovascular disease or respiratory diseases or impaired liver or kidney function. - Mechanical disturbances of the gastro-intestinal tract (torsio ventriculi, incarcerations, oesophageal obstructions). - Diabetes mellitus. - State of shock, emaciation or serious debilitation. Do not use concomitantly with sympathomimetic amines. Do not use in cases of known hypersensitivity to the active substance or to any other excipients. Do not use in animals with ocular problems where an increase in intraocular pressure would be detrimental. See also section 4.7 IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 16/11/2012_ _CRN 7011667_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Medetomidine may not provide analgesia throughout the entire period of sedation, therefore consideration should be given to providing addition Prečítajte si celý dokument